SOC-1: Overall Survival Final Results With Drs. Rongyu Zang And Yulian Chen IJGC podcast

Contenuto fornito da BMJ Group. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da BMJ Group o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

IJGC Podcast »
SOC-1: Overall Survival Final Results with Drs. Rongyu Zang and Yulian Chen

2d ago 32:24

MP3•Pagina principale dell'episodio

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Rongyu Zang and Yulian Chen to discuss the SOC-1 trial. Dr. Rongyu Zang is the Director of the Department of Gynecologic Oncology, Fudan University Zhongshan Hospital, & Institute for Ovarian Cancer, Fudan University and is the Principal investigator of the SOC-1 and SUNNY trials. Dr. Yulian Chen is an Attending Physician at the Department of Gynecologic Oncology, Fudan University Zhongshan Hospital.

Highlights:

The SOC-1 trial concluded that in patients with platinum-sensitive, relapsed ovarian cancer, surgery did not increase overall survival in the intention-to-treat population, but resulted in a prolongation of survival after adjustment of crossover.
Surgery may provide an obviously higher proportion of long-term relapse-free survivors than chemotherapy alone.
An active preoperative evaluation for all patients with platinum-sensitive first relapsed ovarian cancer is suggested in specialized centers.

382 episodi

#BMJ Group #Pedro Ramirez #Fitness #Medicine